Liu 1998.

Methods	Randomisation mentioned, but not described in detail
Participants	Country: China Primary nephrotic syndrome patients (urinary protein > 3.5g/24 h; plasma albumin < 30 g/dL; oedema and hypercholesterolaemia) Number: treatment group (30); control group (28) Age range: 14 to 67 years Sex (M/F): 34/26 Exclusions: secondary nephrotic syndrome
Interventions	Treatment group Huangqi intravenous injection Dose: once a day Drugs the control group received Control group Prednisone Initial dose 1.0mg/kg/d Tripterygium glycosides Dipyridamole Heparin
Outcomes	Effective rate
Notes	Baseline declining kidney function: NS Remission: NS Pathology: NS Relapse: NS Time to relapse: NS Mean follow‐up: NS Dosage: described in detail Prepare method: NS Source of funding: none